Intra-cranial administration of CTLA-4 and PD-1 immune checkpoint-inhibiting monoclonal antibodies in recurrent glioblastoma patients: a multi-cohort adaptive phase I clinical trial

Research output: Unpublished contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 2121
Event26th Annual Meeting and Education Day of the Society for Neuro-Oncology
- Boston, United States
Duration: 18 Nov 202121 Nov 2021

Conference

Conference26th Annual Meeting and Education Day of the Society for Neuro-Oncology
CountryUnited States
CityBoston
Period18/11/2121/11/21

Cite this